ELTX is trading at $3.10 (10.7% up) after Elicio Therapeutics announced the closing of a $15 million registered direct offering on July 7, 2026.
- The offering involved the sale of 4,380,313 shares of common stock and accompanying warrants.
- The stock is seeing a rebound in pre-market hours following a steep decline during the previous trading session.